| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
357,741,000 |
| Market
Cap: |
133.31(B) |
| Last
Volume: |
2,314,661 |
Avg
Vol: |
1,355,641 |
| 52
Week Range: |
$258.49 - $400.59 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
| |
NASDAQ-100 |
|
S&P 400 MIDCAP |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 1071 |
| Guru Rank Value : -4.4 |
| Guru Occurances : 3 |
|
|
|
|
|
| |
|
Company Profile Intuitive Surgical develops, manufactures, and markets the da Vinci® Surgical System and the Ion® endoluminal system. The systems consist of a surgeon console or consoles, a patient-side cart, a vision system, and proprietary instruments and accessories. Co.'s technology is designed to provide surgeons with a range of articulation of the surgical instruments used in the surgical field analogous to the motions of a human wrist, while filtering out the tremor inherent in a surgeon's hand. Co.'s platform for robotic-assisted surgery, da Vinci Surgical System, allows surgeons to operate while seated at a ergonomic console viewing a three-dimensional, high definition image of the surgical field.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
42,991 |
276,305 |
406,582 |
786,177 |
| Total Sell Value |
$16,700,900 |
$106,417,982 |
$146,146,057 |
$241,624,691 |
| Total People Sold |
7 |
11 |
13 |
13 |
| Total Sell Transactions |
22 |
37 |
52 |
79 |
| End Date |
2024-02-29 |
2023-11-28 |
2023-05-30 |
2022-05-30 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Guthart Gary S |
CEO |
• • – |
2024-01-29 |
4 |
AS |
$376.06 |
$9,147,669 |
D/D |
(24,325) |
9,425 |
|
- |
|
| Guthart Gary S |
CEO |
• • – |
2024-01-29 |
4 |
OE |
$51.02 |
$1,721,777 |
D/D |
33,750 |
33,750 |
|
- |
|
| Johnson Amal M |
Director |
– • – |
2024-01-26 |
4 |
AS |
$370.08 |
$2,478,032 |
D/D |
(6,696) |
11,706 |
|
- |
|
| Johnson Amal M |
Director |
– • – |
2024-01-26 |
4 |
OE |
$56.97 |
$381,501 |
D/D |
6,696 |
18,402 |
|
- |
|
| Levy Alan J |
Director |
– • – |
2024-01-26 |
4 |
AS |
$370.20 |
$740,405 |
D/D |
(2,000) |
25,319 |
|
- |
|
| Levy Alan J |
Director |
– • – |
2024-01-26 |
4 |
OE |
$90.49 |
$185,578 |
D/D |
2,000 |
27,247 |
|
- |
|
| Myriam Curet |
EVP & Chief Medical Officer |
• – – |
2024-01-26 |
4 |
AS |
$370.15 |
$1,598,298 |
D/D |
(4,318) |
189 |
|
- |
|
| Myriam Curet |
EVP & Chief Medical Officer |
• – – |
2024-01-26 |
4 |
OE |
$177.99 |
$775,816 |
D/D |
4,318 |
1,689 |
|
- |
|
| Rosa David J. |
President |
• – – |
2023-12-13 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,572 |
154,140 |
|
- |
|
| Johnson Amal M |
Director |
– • – |
2023-11-16 |
4 |
AS |
$300.00 |
$2,870,100 |
D/D |
(9,567) |
11,706 |
|
- |
|
| Johnson Amal M |
Director |
– • – |
2023-11-16 |
4 |
OE |
$41.26 |
$394,713 |
D/D |
9,567 |
21,273 |
|
- |
|
| Myriam Curet |
EVP & Chief Medical Officer |
• – – |
2023-11-16 |
4 |
AS |
$300.00 |
$2,645,700 |
D/D |
(8,819) |
189 |
|
- |
|
| Myriam Curet |
EVP & Chief Medical Officer |
• – – |
2023-11-16 |
4 |
OE |
$166.62 |
$1,525,799 |
D/D |
8,819 |
1,689 |
|
- |
|
| Desantis Robert |
EVP & Chief Strategy & Corp Op |
• – – |
2023-11-14 |
4 |
AS |
$290.00 |
$251,430 |
D/D |
(867) |
7,259 |
|
- |
|
| Desantis Robert |
EVP & Chief Strategy & Corp Op |
• – – |
2023-11-14 |
4 |
OE |
$242.34 |
$212,054 |
D/D |
867 |
7,529 |
|
- |
|
| Levy Alan J |
Director |
– • – |
2023-11-14 |
4 |
AS |
$290.00 |
$580,000 |
D/D |
(2,000) |
25,319 |
|
- |
|
| Levy Alan J |
Director |
– • – |
2023-11-14 |
4 |
OE |
$90.49 |
$180,989 |
D/D |
2,000 |
27,319 |
|
- |
|
| Guthart Gary S |
CEO |
• • – |
2023-10-26 |
4 |
AS |
$260.11 |
$7,123,030 |
D/D |
(27,385) |
23,551 |
|
- |
|
| Guthart Gary S |
CEO |
• • – |
2023-10-26 |
4 |
OE |
$49.34 |
$1,665,336 |
D/D |
33,750 |
50,936 |
|
- |
|
| Guthart Gary S |
CEO |
• • – |
2023-10-24 |
4 |
AS |
$271.93 |
$1,348,773 |
I/I |
(4,960) |
29,840 |
|
- |
|
| Desantis Robert |
EVP & Chief Strategy & Corp Op |
• – – |
2023-10-24 |
4 |
AS |
$271.93 |
$303,574 |
D/D |
(1,110) |
7,259 |
|
- |
|
| Desantis Robert |
EVP & Chief Strategy & Corp Op |
• – – |
2023-10-24 |
4 |
OE |
$177.99 |
$215,468 |
D/D |
1,110 |
7,823 |
|
- |
|
| Loeb Gary |
General Counsel |
• – – |
2023-10-10 |
4 |
D |
$297.83 |
$269,238 |
D/D |
(904) |
1,709 |
|
- |
|
| Loeb Gary |
General Counsel |
• – – |
2023-10-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,613 |
2,613 |
|
- |
|
| Ladd Amy L |
Director |
– • – |
2023-09-14 |
4 |
AS |
$305.68 |
$152,840 |
D/D |
(500) |
702 |
|
- |
|
2148 Records found
|
|
Page 6 of 86 |
|
|
5.92 (1.56%) 
